Cardiovascular Injury Due to SARS-CoV-2.

Christina L BugertVictoria KwiatIsela C ValeraJoachim J BugertMichelle S Parvatiyar

Published in: Current clinical microbiology reports (2021)

During the past year, COVID-19 patient mortality rates have improved due to tailored pharmacological treatments and patient management strategies that address the unique presentation of symptoms, which will hopefully also reduce the incidence of cardiac injury.

Keyphrases

sars cov
case report
coronavirus disease
risk factors
left ventricular
cardiovascular events
smoking cessation
coronary artery disease